MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group ...
India has become a global hub for Global Capability Centres (GCCs) and AI-led innovation, driving high demand for specialized ...
A study has found that taking daily multivitamins may slow the aging process. The research team from Brigham and Women’s Hospital, Harvard Medical School, published their analysis comparing ...